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Mutational 
Mechanisms
To probe the mutational 
mechanisms of the 
loss of heterozygosity 
(LOH) of the NF1 gene in 
neurofibromatosis type 1, 
Steinmann and colleagues 
investigated 43 plexiform 
neurofibromas, which can 
transform into malignant 
tumors. No significant 
differences were found 
between dermal and 
plexiform neurofibromas 
with respect to the 
extent of LOH or 
mutational mechanisms. 
Interestingly, although 
nonallelic homologous 
recombination has 
been reported to 
underlie the majority of 
microdeletions of NF1, 
mitotic recombination 
events were observed 
in 46% of the plexiform 
neurofibromas, suggesting 
that this mechanism occurs 
frequently in these benign 
tumors. See page 615
Physical Barrier Defects
Since the identification of filaggrin mutations in atopic 
dermatitis (AD) patients, the function of the epidermal bar-
rier in this common skin disease has come under intense 
scrutiny. Nemoto-Hasebe and colleagues examined skin 
barrier function via transepidermal water loss and stratum 
corneum hydration and thickness in AD patients with and 
without filaggrin mutations. Considerable barrier dysfunc-
tion was indicated by the correlations between the AD 
severity score and the three parameters of skin barrier only 
in patients with filaggrin-related AD. These results suggest 
that epidermal barrier defects may, in fact, be the primary 
abnormality in filaggrin-related AD. See page 682
Chemical Barrier to Infection
Patients with AD suffer from frequent skin infec-
tions. Both disrupted permeability barrier and 
impaired antimicrobial peptide (AMP) produc-
tion may facilitate these infections; however, 
AD patients rarely suffer from infections by the 
common gut pathogen E. coli. Gläser and col-
leagues found that psoriasin, which exhibits high 
bactericidal activity against E. coli, was actually 
increased in AD skin and that secretion of this 
AMP was enhanced following experimental dis-
ruption of the skin barrier. Taken together, these 
results suggest that general skin barrier disruption 
may be a critical force in increasing psoriasin 
secretion, although the contribution of cytokine 
to this chemical barrier AMP regulation remains 
to be elucidated. See page 641
Prolonging Neutrophil Survival
Carcinoembryonic antigen-related cell-
ular adhesion molecule 1 (CEACAM1) 
is a cell-surface antigen involved in 
adhesion and signaling. Rahmoun and 
colleagues discovered that this protein 
is not expressed by healthy keratinocytes 
but is upregulated during inflammation 
in the outer epidermis of psoriatic 
lesional skin. This cytokine-induced 
cell-surface expression of CEACAM1 on 
keratinocytes may prolong the survival 
of neutrophils, which are typically present in microabscesses in psoriatic lesions 
and undergo apoptosis rapidly after leaving the circulation. This prolonged sur-
vival would promote the ongoing inflammation that is characteristic of psoriasis. 
CEACAM1 may thus serve as a valuable biological marker for diagnosis of the 
disease. See page 671
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